ACR Gears Up For Key State Legislative Issues Including AI
ACR joined physician leaders at the AMA summit to address Medicaid, payer issues, physician-led care, wellness, and emerging AI legislation in states.
Read more
President Trump and his administration have revived efforts to require hospitals and health plans to disclose their prices and rates to patients. The administration issued an executive order Feb. 25, that mandates the secretaries of Labor, Treasury and Health and Human Services (HHS) implement price transparency regulations by late May.i
The first Trump administration issued an executive order in 2019, that directed pricing transparency and then finalized a rule to implement it. Hospitals challenged that rule in court, but complied slowly when it was upheld.ii The new executive order requires the government to accelerate regulatory enforcement.
Specifically, the three departments must require healthcare entities to disclose the actual prices of medical items and services, not estimates. Additionally, they must provide current guidance or proposed regulations to facilitate standard, comparable pricing information across hospitals and health plans. They also must offer guidance or proposed rules to enforce compliance.
Notably, the 2019 final rule based on the prior executive order listed more than a dozen imaging services for which hospitals were to disclose pricing. Those included MRIs of the leg joints, lower back X-rays and CT imaging of the pelvis with contrast. HHS cited 18 studies that determined displaying charges for radiology services changed ordering physicians’ behavior and reduced costs.iii
The College is closely monitoring this significant development. If you have questions or would like more information, contact Katie Keysor, ACR® Senior Director, Economic Policy, Economics.
ACR Gears Up For Key State Legislative Issues Including AI
ACR joined physician leaders at the AMA summit to address Medicaid, payer issues, physician-led care, wellness, and emerging AI legislation in states.
Read more
FDA Updates Guidance on Clinical Decision Support
FDA’s 2026 CDS update clarifies which software is regulated, affirming oversight of image‑analysis tools while exempting certain guideline‑based CDS.
Read moreStates Begin to Introduce Bills for 2026
States launch 2026 sessions with new bills on AI governance, rural radiation therapy, imaging workforce standards, and dose rules.
Read more